针对抗体的人造T细胞和天然杀手细胞衍生膀用于癌症免疫疗法
Brijesh Parlekar1, David W Livingstone1, Ashley R Sutherland2
1Department of Health Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Journal of extracellular vesicles
|January 31, 2026
概括
来自T和NK92细胞的抗体结合的人造细胞衍生囊泡 (ACDV) 显示出增强的抗癌活性. 向的NK92 ACDVs有效降低了小鼠的瘤体积,并在白血病活检中显示出细胞毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 在瘤学瘤学.
背景情况:
- 来自T和NK92细胞的人工细胞衍生囊泡 (ACDV) 通过细胞毒性蛋白和受体具有抗癌特性.
- 加强ACDV向的现有方法,如基因工程,是低效和昂贵的.
- 自然衍生的外生体产量有限,需要采用替代方法.
研究的目的:
- 为了比较来自激活的T细胞和NK92细胞的向和非向ACDV.
- 评估抗体结合在向癌细胞的ACDVs中的有效性.
- 在临床前模型中评估抗体结合ACDVs的抗癌潜力.
主要方法:
- 激活的T细胞和NK92细胞被用来产生ACDVs.
- ACDVs与瘤向抗体结合 (14f7hT用于GM3lioside,尼莫图祖马布用于EGFR).
- 针对性和非针对性ACDV的相互作用,内化和细胞毒性对癌细胞进行了测试,随后进行了体内和体外研究.
主要成果:
- 针对抗体显著改善了ACDV相互作用,内化和癌细胞杀死.
- 在T-ACDV中保留了穿孔素,酶,FasL和TRAIL;在NK92 ACDV中保留了穿孔素,酶和FasL.
- 尼莫图祖马布结合的NK92 ACDVs在表达EGFR的卵巢癌异体移植中降低了瘤体积.
- 与14F7hT结合的NK92 ACDVs在慢性淋巴细胞白血病活检中表现出细胞毒性.
结论:
- 抗体结合增强了T和NK92 ACDVs的瘤向和细胞毒性能力.
- NK92 ACDVs为向癌症免疫治疗提供了一个具有成本效益和可生产的平台.
- 抗体结合的NK92 ACDVs是有效瘤向免疫治疗的有希望的策略.
更多相关视频
相关概念视频
Natural and Artificial Concepts
567
In psychology, concepts can be divided into two categories: natural and artificial. Natural concepts are formed through direct or indirect experiences. For example, consider the concept of snow. If you live in a place with regular snowfall, such as Essex Junction, Vermont, you know snow through direct experiences. You’ve seen it fall, touched it, shoveled it, and played in it. You recognize its texture, appearance, and even its smell. In contrast, if you live on an island like Saint...
567
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Tumor Immunotherapy
1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Nature and Nurture
22.3K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.3K
Target Cell Response to Hormones
5.7K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K
Cancer Cell Migration through Invadopodia
3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K


